<p>，/PRNewswire/ -- Zynex, Inc. 今天宣布已解决联邦政府对公司前高管设计和实施的商业行为的调查。在今天签署的不起诉协议（NPA）下，罗德岛地区美国检察官办公室（USAO RI）同意不对公司提起刑事指控，并且不要求未来进行独立合规监控。</p>
<p>首席执行官 Steven Dyson 表示：“我们今天达成的解决方案代表了我们作为新管理团队在 2025 年 8 月到任时所做承诺的实现：摆脱过去，重建公司，使其合规设计，并为公司、客户和员工创造一个新的未来。我们的客户和患者从我们高效的产品中获得了切实的好处，但不幸的是，这些好处被以往的商业行为所掩盖。我们整个团队花了六个月的时间专注于重建组织的每一个部分，关注最重要的事情：在我们所做的一切中保持透明、诚信和合规，以确保我们的高质量产品得到高质量运营的支持。”</p>
<p>USAO RI 在考虑到公司 “广泛的补救措施”、“管理团队设计的内部控制以检测和阻止不当计费” 以及公司对调查的合作后，做出了不起诉的决定。</p>
<p>首席法律官 John Bibb 表示：“我们已经完全改革了从订单到现金的流程，并实施了严格的企业合规程序。我们积极实施补救措施和控制，以便将过去抛在脑后。通过采用公认的耐用医疗设备（DME）运营和合规最佳实践，我们为未来奠定了坚实的基础。通过今天的公告，我们迅速结束了一系列在新管理层到来之前就已开始的调查。”</p>
<p>自 2025 年 8 月以来，新管理层对公司的商业行为、合规程序和运营控制实施了重大变革，包括但不限于：</p>
<ul>
<li>完全重新设计供应补充实践 - 要求患者在发货前明确及时确认他们需要新供应品。</li>
<li>新的订单接收和履行实践，在接收时落实医疗必要性和付款方要求。</li>
<li>新的控制措施停止旨在规避付款方要求的计费行为，包括对供应品的拆分计费。我们现在要求并确保严格遵守付款方计费指南。</li>
<li>新政策确保我们的营销活动符合标签要求，并与 FDA 的期望一致。</li>
</ul>
<p>Zynex 于 2025 年 12 月 15 日在德克萨斯州南区休斯顿的美国破产法院根据美国破产法第 11 章申请自愿财务重组。随着这一解决方案的到位，公司预计将在未来几个月内从第 11 章财务重组中脱颖而出。</p>
<p><strong>关于 Zynex, Inc.</strong></p>
<p>Zynex 成立于 1996 年，是一家疼痛管理设备的制造商和分销商。有关更多信息，请访问：www.zynex.com。</p>
<p><strong>媒体联系人：</strong> Britt Logan DiGiulio</p>
<p>电子邮件：[email protected]</p>
<p>来源：Zynex, Inc.</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjE3Jk5ld3NJdGVtSWQ9TEE4OTg5MiZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMTcxNjIyUFJfTkVXU19VU1BSX19fX19MQTg5ODky?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjE3Jk5ld3NJdGVtSWQ9TEE4OTg5MiZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMTcxNjIyUFJfTkVXU19VU1BSX19fX19MQTg5ODky"/></p>

ZYXIQ

<p>Zynex, Inc. 已经解决了对其商业行为的联邦调查，美国检察官办公室同意不追究刑事指控。自 2025 年 8 月以来，该公司在新管理层的领导下实施了广泛的变革，以确保合规性和透明度。首席执行官 Steven Dyson 强调了重建公司的承诺，并专注于高质量的运营。Zynex 预计将在未来几个月内从第 11 章破产重组中走出，此前进行了重大运营改革并遵循了付款方账单指南</p>

<p>, /PRNewswire/ -- Zynex, Inc., today announced that it has resolved the federal government's investigation into business practices designed and implemented by the company's former executives. Under the non-prosecution agreement (NPA) signed today, the United States Attorney's Office for the District of Rhode Island (USAO RI) has agreed not to pursue criminal charges against the company and not to require an independent compliance monitor going forward.</p>
<div class="lb-trans"><p>，/PRNewswire/ -- Zynex, Inc. 今天宣布已解决联邦政府对公司前高管设计和实施的商业行为的调查。在今天签署的不起诉协议（NPA）下，罗德岛地区美国检察官办公室（USAO RI）同意不对公司提起刑事指控，并且不要求未来进行独立合规监控。</p>
</div><p>&#34;The resolution we have achieved today represents the fulfillment of the commitments we made as a new management team when we arrived in August 2025: to break from the past, rebuild the company as compliant-by-design, and create a new future for the company, its customers, and employees,&#34; said Steven Dyson, Chief Executive Officer. &#34;Our customers and patients experience a very real benefit from our highly effective products, which has unfortunately been overshadowed by previous business practices. Our entire team has spent six months singularly focused on rebuilding every part of our organization to focus on what matters most: transparency, integrity, and compliance in everything we do so that our high-quality products are supported by high-quality operations.&#34;</p>
<div class="lb-trans"><p>首席执行官 Steven Dyson 表示：“我们今天达成的解决方案代表了我们作为新管理团队在 2025 年 8 月到任时所做承诺的实现：摆脱过去，重建公司，使其合规设计，并为公司、客户和员工创造一个新的未来。我们的客户和患者从我们高效的产品中获得了切实的好处，但不幸的是，这些好处被以往的商业行为所掩盖。我们整个团队花了六个月的时间专注于重建组织的每一个部分，关注最重要的事情：在我们所做的一切中保持透明、诚信和合规，以确保我们的高质量产品得到高质量运营的支持。”</p>
</div><p>The USAO RI reached its non-prosecution decision in light of the company's &#34;extensive remedial measures,&#34; the &#34;internal controls [the management team] designed to detect and deter improper billing,&#34; and the company's cooperation with the investigation.</p>
<div class="lb-trans"><p>USAO RI 在考虑到公司 “广泛的补救措施”、“管理团队设计的内部控制以检测和阻止不当计费” 以及公司对调查的合作后，做出了不起诉的决定。</p>
</div><p>&#34;We have completely overhauled our order-to-cash processes and implemented a rigorous corporate compliance program,&#34; said John Bibb, Chief Legal Officer. &#34;We have aggressively implemented remediation and controls in order to put the past behind us. By adopting well-accepted durable medical equipment (DME) operational and compliance best practices, we have set a strong foundation for the future. With today's announcement, we have swiftly brought to close a series of investigations that began long before new management arrived.&#34;</p>
<div class="lb-trans"><p>首席法律官 John Bibb 表示：“我们已经完全改革了从订单到现金的流程，并实施了严格的企业合规程序。我们积极实施补救措施和控制，以便将过去抛在脑后。通过采用公认的耐用医疗设备（DME）运营和合规最佳实践，我们为未来奠定了坚实的基础。通过今天的公告，我们迅速结束了一系列在新管理层到来之前就已开始的调查。”</p>
</div><p>Since August 2025, new management has implemented significant changes to the company's business practices, compliance program, and operational controls, including, among other items:</p>
<div class="lb-trans"><p>自 2025 年 8 月以来，新管理层对公司的商业行为、合规程序和运营控制实施了重大变革，包括但不限于：</p>
</div><ul>
<li>Complete redesign of supplies replenishment practices - requiring explicit and timely confirmation from patients that they need new supplies prior to shipment.</li>
<li>New order intake and fulfilment practices that operationalize medical necessity and payor requirements at the point of intake.</li>
<li>New controls that put a stop to billing practices designed to circumvent payor requirements, including unbundling of supplies. We now require and ensure strict adherence to payor billing guidelines.</li>
<li>New policies ensuring that our marketing activities are on-label and consistent with FDA expectations.</li>
</ul>
<div class="lb-trans"><ul>
<li>完全重新设计供应补充实践 - 要求患者在发货前明确及时确认他们需要新供应品。</li>
<li>新的订单接收和履行实践，在接收时落实医疗必要性和付款方要求。</li>
<li>新的控制措施停止旨在规避付款方要求的计费行为，包括对供应品的拆分计费。我们现在要求并确保严格遵守付款方计费指南。</li>
<li>新政策确保我们的营销活动符合标签要求，并与 FDA 的期望一致。</li>
</ul>
</div><p>Zynex filed for a voluntary financial reorganization under Chapter 11 of the U.S. Bankruptcy Code on December 15, 2025, in the U.S. Bankruptcy Court for the Southern District of Texas, Houston division. With this resolution now in place, the company expects to emerge from Chapter 11 financial restructuring in the next few months.</p>
<div class="lb-trans"><p>Zynex 于 2025 年 12 月 15 日在德克萨斯州南区休斯顿的美国破产法院根据美国破产法第 11 章申请自愿财务重组。随着这一解决方案的到位，公司预计将在未来几个月内从第 11 章财务重组中脱颖而出。</p>
</div><p><strong>About Zynex, Inc.</strong></p>
<div class="lb-trans"><p><strong>关于 Zynex, Inc.</strong></p>
</div><p>Zynex, founded in 1996, is a pain management device manufacturer and distributor. For additional information, visit: www.zynex.com.</p>
<div class="lb-trans"><p>Zynex 成立于 1996 年，是一家疼痛管理设备的制造商和分销商。有关更多信息，请访问：www.zynex.com。</p>
</div><p><strong>Media Contact:</strong> Britt Logan DiGiulio</p>
<div class="lb-trans"><p><strong>媒体联系人：</strong> Britt Logan DiGiulio</p>
</div><p>Email: [email protected]</p>
<div class="lb-trans"><p>电子邮件：[email protected]</p>
</div><p>SOURCE Zynex, Inc.</p>
<div class="lb-trans"><p>来源：Zynex, Inc.</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjE3Jk5ld3NJdGVtSWQ9TEE4OTg5MiZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMTcxNjIyUFJfTkVXU19VU1BSX19fX19MQTg5ODky" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA89892&amp;Transmission_Id=202602171622PR_NEWS_USPR_____LA89892&amp;DateId=20260217"/></p>

Zynex 在联邦调查解决后准备迎接新的未来